About Hansen Medical
Hansen Medical makes an electromechanical robotic system which provides accurate and efficient control over catheter movement during interventional procedures. The system is controlled by the physician from a workstation that integrates visualization, guidance, and patient physiologic data. (NASDAQ: HNSN).
Expert Collections containing Hansen Medical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Hansen Medical is included in 2 Expert Collections, including Robotics.
This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Hansen Medical Patents
Hansen Medical has filed 174 patents.
Surgical instruments, Medical equipment, Catheters, Sensors, Surgery
Surgical instruments, Medical equipment, Catheters, Sensors, Surgery
Latest Hansen Medical News
Oct 10, 2023
Robotic Catheterization Systems Market Poised to Reach US$ 112.5 Million by 2029 The robotic catheterization systems market is anticipated to reach US$ 42.9 million in 2022 and expand at a 14.8% CAGR through 2029. Percutaneous Coronary Intervention applications will make up about 73.9% of the market for robotic catheterization systems globally in 2021, predicts Future Market Insights. Interventional and surgical robotic systems have already made a significant impact on how surgeries are performed and are being increasingly adopted in modern operating rooms. Robotic catheterization systems have proved their abilities to perform interventional procedures with immensely low operator radiation exposure in comparison to the tradition catheterization procedures. Procedures where clinicians are given navigational and mechanical tools that permit definite actions or part of the procedure to be executed autonomously with a level of precession and control are possible only with robot-assisted catheterization. Get a Sample Copy of the Report: Key Takeaways – Robotic Catheterization Systems Market Study Popularity of robotic catheterization systems, increasing system awareness, improving reimbursement scenarios for percutaneous coronary intervention (PCI), larger patient pool for coronary artery diseases are key factors influencing the robotic catheterization systems market in developed countries. High upfront cost is posing a negative impact on end users’ decision to purchase robotic catheterized systems. To rework this problem, Hansen Medical is offering sensei system at a competitive pricing depicting lower accessory cost and lower total cost per procedure. Robotic catheterization systems installed in Chesapeake Regional Healthcare marks as the first fully integrated catheterization laboratory installed in its all intervention operating room. In terms of product type, electromechanical robotic catheterization systems with comparatively higher technical advantage over magnetic-guided robotic catheterization systems is expected to generate significant revenue. In terms of application, increasing adoption of robotic catheterization for percutaneous coronary intervention as compared to cardiac electrophysiology procedure marks higher revenue potential. Unlock exclusive insights with our expert analysts: Market Leaders on Acquisition Spree In reference to the trend in other medical device markets, key factors impacting the robotic catheterization systems market are partnerships and mergers observed in recent years. Key manufacturers are entering the robotic catheterization systems market by strategically expanding their reach through acquisitions and mergers, considering the increasing demand for these systems. Product bundling of robotic catheterization and accessory systems at promotional rates and research contracts are forcing a decline in ASPs. Companies are focusing on limiting operational expenses to grow profitability. In contrast to these market changes, another significant factor influencing the robotic catheterization systems market is the exit and entrance of co-participating companies. In August 2022, Corindus Vascular Robotics Inc., a prominent developer of precision vascular robotics, declared that it has settled on acquisition by Siemens Healthineers AG., representing a collective purchase price of approximately $1.1 billion. In April 2016, Hansen Medical Inc. was acquired by Auris Surgical Robotics Inc. in an arrangement with roughly US$ 80 Mn of equity value. With Hansen portfolio, Auris attained Magellan Robotic System, employed in navigating peripheral blood vessels in endovascular procedures, and Sensei Robotic System, a robotically steerable catheter system. Key Market Segments: Insights Designed for You: Customize Your Exclusive Report Today : About Future Market Insights (FMI) Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Contact Us:
Hansen Medical Frequently Asked Questions (FAQ)
When was Hansen Medical founded?
Hansen Medical was founded in 2002.
Where is Hansen Medical's headquarters?
Hansen Medical's headquarters is located at 800 East Middlefield Road, Mountain View.
What is Hansen Medical's latest funding round?
Hansen Medical's latest funding round is Acquired.
How much did Hansen Medical raise?
Hansen Medical raised a total of $57.8M.
Who are the investors of Hansen Medical?
Investors of Hansen Medical include Auris Health, Prospect Venture Partners, Skyline Ventures, De Novo Ventures, Thomas Weisel Partners and 6 more.
Who are Hansen Medical's competitors?
Competitors of Hansen Medical include CMR Surgical, Activ Surgical, Vicarious Surgical, Quantum Surgical, Medrobotics and 7 more.
Compare Hansen Medical to Competitors
Quantum Surgical is a medical device company that focuses on healthcare innovation, particularly in the domain of medical robotics. The company's main offering is a robotic-assisted technology, which is designed to plan, target, deliver, and confirm tumor ablation, thereby enabling more patients to benefit from better-targeted and less invasive treatments. Quantum Surgical primarily serves the healthcare industry, with a specific focus on interventional oncology. It was founded in 2017 and is based in Montpellier, France.
CMR Surgical operates as a surgical robotics company developing universal robotic systems for minimal access surgery. It aims to make minimal-access surgery universally accessible and affordable by expanding the range of procedures that can be performed robotically. CMR Surgical was formerly known as Cambridge Medical Robotics. It was founded in 2014 and is based in Cambridge, United Kingdom.
Activ Surgical is a digital surgery company that focuses on enhanced real-time visualization capabilities for surgeons. The company develops and strengthens software combining advanced augmented reality (AR), artificial intelligence (AI), and machine learning (ML) technology. Its products include ActivSight, ActivEdge, ActivPerfusion, and ActivICG. The company was founded in 2017 and is based in Boston, Massachusetts.
Intuitive Surgical develops, manufactures and markets robotic surgical systems under the da Vinci Surgical brand.
Bionaut Labs operates as a precision biotechnology company. It designs and manufactures intra- tissue navigation using Bionaut nano, microrobots operating inside the body. It offers remote-controlled micro-robots revolutionizing the treatment of central nervous system (CNS) disorders targeting deep brain structures. Its devices cater to therapeutic, microsurgical, diagnostic, sensing, monitoring, and stimulatory issues. The company was founded in 2016 and is based in Los Angeles, California.
Theator develops surgical intelligence in healthcare. The company offers a platform that uses advanced artificial intelligence (AI) and computer vision technology to capture, analyze, and extract valuable surgical data, aiming to provide meaningful insights and best practices throughout a patient's surgical journey. It primarily serves hospitals and surgeons. It was founded in 2018 and is based in Palo Alto, California.